Molecular profile
Molecular profile
- Molecule class
- Synthetic peptide
- Origin
- Synthetic
- Primary target system
- GHSR1a/Ghrelinrezeptor
- Development stage
- Clinical development
Synthetisches Pentapeptid und selektiver Ghrelinrezeptor-Agonist.
Mechanism and signalling
Mechanism and signalling
Binding to GHSR1a can trigger growth-hormone pulses. Selectivity and hormonal effects depend on dose, model and study design.
Scientific classification
Scientific classification
This profile maps Ipamorelin to the research areas endocrine, metabolism. Molecule class, evidence level, development stage and regulatory status are separated so that preclinical findings are not confused with authorised uses.
Peptide hormones and analogues related to hypothalamic, pituitary and peripheral endocrine systems.
Pathways related to glucose homeostasis, appetite, energy expenditure and body composition.
Evidence base
Early human data
Early human studies exist, but development has not resulted in general medicinal approval. Long-term safety data are limited.
Regulatory status
Not generally authorised
This research substance has no general medicinal authorisation in Germany or the EU. Labels such as “research peptide” do not replace regulatory approval.
Safety and use notice
No dosing or administration recommendation
The available evidence does not establish safe self-directed use. This profile intentionally provides no dosing, sourcing or administration guidance.
Sources and registries